Skip to main content

Lucira Health, Inc.

LHDXDelisted Apr 12, 2023
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652724

Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Lucira Health, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LHDX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5144−7
Shares19.3M16.3M−3.05M (−15.8%)
Value$233.6M$107.9M−$125.7M (−53.8%)

New holders (19)

Institutions that held Lucira Health, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LHDX in Q2 2021
InstitutionSharesValue% of portfolio
Pura Vida Investments, LLC400,000$2.66M0.19%
Ieq Capital, LLC46,175$307.0K0.01%
Ergoteles LLC42,498$282.0K0.01%
Millennium Management LLC39,430$262.0K0.00%
Tibra Equities Europe Ltd34,400$228.0K0.07%
Walleye Capital LLC30,878$205.0K0.01%
HRT Financial LP23,544$156.0K0.00%
Paloma Partners Management Co19,312$128.0K0.00%
Price T Rowe Associates Inc14,800$98.0K0.00%
Point72 Hong Kong Ltd13,110$87.0K0.01%
TrinityPoint Wealth, LLC12,000$80.0K0.02%
Walleye Trading LLC10,293$68.0K0.00%
Group One Trading, L.P.2,085$14.0K0.00%
Gemmer Asset Management LLC500$3.00K0.00%
Captrust Financial Advisors319$2.00K0.00%
Cubist Systematic Strategies, LLC234$2.00K0.00%
Howe & Rusling Inc200$1.00K0.00%
Simplex Trading, LLC43$00.00%
Advisory Services Network, LLC10$00.00%

Sold out (26)

Institutions that held Lucira Health, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.